Personal Information
Organization / Workplace
Lucknow Area, India India
Occupation
Assistant Professor
Industry
Medical / Health Care / Pharmaceuticals
About
I'm presently employed as an Assistant Professor in Dr. KNSMIMS, Lucknow. I've also worked as an Assistant Professor in Kannur Medical College, Kerala for 1 year and 2 months
Tags
autonomic nervous system
beta blockers
atropine
acetylcholine
propranolol
calcium channel blockers
cns drugs
diuretics
aspirin
half life
absorption
first pass metabolism
volume of distribution
nitrates
angina
glp-1 analogues
gliptins
meglitinde analogues
metformin
sulfonylureas
oral antidiabetic drugs
diabetes mellitus type 2
mechanism of action
classification
general considerations
antimicrobials
skeletal muscle relaxants
general anaesthetics
drugs affecting blood
drugs & aids in dental
cardiovascular system drugs
psychopharmacology
autacoids
anti-viral drugs
anti leprosy drugs
anti-tb
disinfectants
antiseptics
antiprotozoal drugs
anti-fungal drugs
anti-cancer drugs
case introduction
justice
nonmaleficence
beneficence
autonomy
bioethics
communication
ethics and c
attitude
aetcom
type b effects
type a effects
adverse drug reaction
adr
adverse drug effects
classification of seizures
status epilepticus
seizures
epilepsy
antiepileptic
neuropharmacology
pharmacology
digitalis toxicity
thyrotoxicosis
pindolol
hypertension
drug interactions
contraindications
beta 3
beta 2
beta 1
acebutolol
sotalol
bisoprolol
heart failure
side effects
uses
atenolol
timolol
drug receptors
affinity
efficacy
g protein coupled receptors
excretion
imipramine antiepileptics cbmz
ibup.
gabap.
pregabalin
indo.
pcm
nsaids asp.
nort.
diclofenac tcas amit.
opioid strong opioid agonists morphine
pentazocine
loperamide
meperidine
diphenoxylate
hydrocodone other opioid agonists dextromethor
nalbuphine
methadone moderate opioid agonists codeine
tramadol
tapentadol mixed opioid agonist-antagonists bupre
fentanyl (its derivatives)
propiphenazone. benzoxazocine derivative: nefopam
etoricoxib
diclofenac
preferential cox-2 inhibitors nimesulide
parecoxib d. analgesic-antipyretics with poor anti
aceclofenac c. selective cox-2 inhibitors cele
indomethacin pyrazolone derivatives phenylbutazon
tenoxicam acetic acid derivatives ketorolac
flurbiprofen fenamate mephenamic acid. enolic
salicylates aspirin. propionic acid derivative
ibuprofen
drug names
history of pharmacology
routes of drug administration
sodium cromoglycate
tiotropium
zileuton
ipratropium
theophylline
salbutamol
prednisolonem montelukast
terbutaline
zafirlukast
aminophylline
ephedrine
epinephrine
hydralazine
digoxin
nesiritide
dobutamine
vasodilators
amoxapine;
doxepin ;desipramine
duloxetine 5. atypical antidepressants trazodone
selective serotonin reuptake inhibitors (ssris) fl
mirtazapine
tricyclic antidepressants (tcas) na + 5-ht reuptak
fluvoxamine
escitalopram
paroxetine
sertraline
clorgyline (mao a) selegiline mao-b
dapoxetine 4. serotonin and noradrenaline reuptake
bupropion
mianserin
citalopram
phenelzine
clomipramine
nortriptyline
amitriptyline
tranylcypromine (mao-a+b) 2nd gen. moclobemide
eptifibatide
dipyridamole
abciximab
streptokinase
heparin
anticoagulant
antiplatelet
clopidogrel
ticlopidine
warfarin
coagulant
organophosphorous
bethanechol
carbachol
angiotensin receptor blockers
angiotensin converting enzyme inhibitors
anti-hypertensive drugs
sympathetic
cholinergic
anti cholinergic
anti adrenergic
alpha and beta receptors
doxazosin
prazosin
parasympathetic
muscarinic receptors
adrenergic
calcium chloride
potassium chloride
noradrenaline
isoprenaline
adrenaline
cardiac stimulant
cardiac depressant
indirect acting
direct acting
effect of drugs on frogs's heart
organs on chips
demyelinating diseases
umbilical cord stem cells
multiple sclerosis
spinal cord injury
type 1 diabetes
eye
deafness
stem cell therapy
parkinson's disease
baldness
n-acetylcysteine
olanzapine
raloxifene
aripiprazole
atypical antipsychotics
estrogen
quetiapine
ziprasidone
clozapine
second generation antipsychotics
minocycline
risperidone
salt factor
relative bioavailability
clinical equivalence
tmax
pharmacokinetics
bioavailability
therapeutic equivalence
zero order kinetics
clearance
bioequivalence
cmax
elimination rate constant
distribution equilibrium
absolute bioavailability
first order kinetics
mixed order kinetics
common rule
nuremberg code
who guidelines of gcp
ich guidelines of gcp
declaration of helsinki
belmont report
clinical trial
ind
clinical trials
preclinical development
target selection
transgenic animals
lead finding
dna microarray
target validation
regulatory approval
0
2
phase 1
drug discovery
nda
lead optimization
drug development
lead compound
marketing of drug
spectrophotometer
absorbance
beer's law
lambert's law
colorimetry
spectroscopy
transmittance
potassium channel openers
anti-angina
See more
Presentations
(43)Likes
(1)Different Forms of Drug Formulation
Cognibrain Healthcare
•
5 years ago
Personal Information
Organization / Workplace
Lucknow Area, India India
Occupation
Assistant Professor
Industry
Medical / Health Care / Pharmaceuticals
About
I'm presently employed as an Assistant Professor in Dr. KNSMIMS, Lucknow. I've also worked as an Assistant Professor in Kannur Medical College, Kerala for 1 year and 2 months
Tags
autonomic nervous system
beta blockers
atropine
acetylcholine
propranolol
calcium channel blockers
cns drugs
diuretics
aspirin
half life
absorption
first pass metabolism
volume of distribution
nitrates
angina
glp-1 analogues
gliptins
meglitinde analogues
metformin
sulfonylureas
oral antidiabetic drugs
diabetes mellitus type 2
mechanism of action
classification
general considerations
antimicrobials
skeletal muscle relaxants
general anaesthetics
drugs affecting blood
drugs & aids in dental
cardiovascular system drugs
psychopharmacology
autacoids
anti-viral drugs
anti leprosy drugs
anti-tb
disinfectants
antiseptics
antiprotozoal drugs
anti-fungal drugs
anti-cancer drugs
case introduction
justice
nonmaleficence
beneficence
autonomy
bioethics
communication
ethics and c
attitude
aetcom
type b effects
type a effects
adverse drug reaction
adr
adverse drug effects
classification of seizures
status epilepticus
seizures
epilepsy
antiepileptic
neuropharmacology
pharmacology
digitalis toxicity
thyrotoxicosis
pindolol
hypertension
drug interactions
contraindications
beta 3
beta 2
beta 1
acebutolol
sotalol
bisoprolol
heart failure
side effects
uses
atenolol
timolol
drug receptors
affinity
efficacy
g protein coupled receptors
excretion
imipramine antiepileptics cbmz
ibup.
gabap.
pregabalin
indo.
pcm
nsaids asp.
nort.
diclofenac tcas amit.
opioid strong opioid agonists morphine
pentazocine
loperamide
meperidine
diphenoxylate
hydrocodone other opioid agonists dextromethor
nalbuphine
methadone moderate opioid agonists codeine
tramadol
tapentadol mixed opioid agonist-antagonists bupre
fentanyl (its derivatives)
propiphenazone. benzoxazocine derivative: nefopam
etoricoxib
diclofenac
preferential cox-2 inhibitors nimesulide
parecoxib d. analgesic-antipyretics with poor anti
aceclofenac c. selective cox-2 inhibitors cele
indomethacin pyrazolone derivatives phenylbutazon
tenoxicam acetic acid derivatives ketorolac
flurbiprofen fenamate mephenamic acid. enolic
salicylates aspirin. propionic acid derivative
ibuprofen
drug names
history of pharmacology
routes of drug administration
sodium cromoglycate
tiotropium
zileuton
ipratropium
theophylline
salbutamol
prednisolonem montelukast
terbutaline
zafirlukast
aminophylline
ephedrine
epinephrine
hydralazine
digoxin
nesiritide
dobutamine
vasodilators
amoxapine;
doxepin ;desipramine
duloxetine 5. atypical antidepressants trazodone
selective serotonin reuptake inhibitors (ssris) fl
mirtazapine
tricyclic antidepressants (tcas) na + 5-ht reuptak
fluvoxamine
escitalopram
paroxetine
sertraline
clorgyline (mao a) selegiline mao-b
dapoxetine 4. serotonin and noradrenaline reuptake
bupropion
mianserin
citalopram
phenelzine
clomipramine
nortriptyline
amitriptyline
tranylcypromine (mao-a+b) 2nd gen. moclobemide
eptifibatide
dipyridamole
abciximab
streptokinase
heparin
anticoagulant
antiplatelet
clopidogrel
ticlopidine
warfarin
coagulant
organophosphorous
bethanechol
carbachol
angiotensin receptor blockers
angiotensin converting enzyme inhibitors
anti-hypertensive drugs
sympathetic
cholinergic
anti cholinergic
anti adrenergic
alpha and beta receptors
doxazosin
prazosin
parasympathetic
muscarinic receptors
adrenergic
calcium chloride
potassium chloride
noradrenaline
isoprenaline
adrenaline
cardiac stimulant
cardiac depressant
indirect acting
direct acting
effect of drugs on frogs's heart
organs on chips
demyelinating diseases
umbilical cord stem cells
multiple sclerosis
spinal cord injury
type 1 diabetes
eye
deafness
stem cell therapy
parkinson's disease
baldness
n-acetylcysteine
olanzapine
raloxifene
aripiprazole
atypical antipsychotics
estrogen
quetiapine
ziprasidone
clozapine
second generation antipsychotics
minocycline
risperidone
salt factor
relative bioavailability
clinical equivalence
tmax
pharmacokinetics
bioavailability
therapeutic equivalence
zero order kinetics
clearance
bioequivalence
cmax
elimination rate constant
distribution equilibrium
absolute bioavailability
first order kinetics
mixed order kinetics
common rule
nuremberg code
who guidelines of gcp
ich guidelines of gcp
declaration of helsinki
belmont report
clinical trial
ind
clinical trials
preclinical development
target selection
transgenic animals
lead finding
dna microarray
target validation
regulatory approval
0
2
phase 1
drug discovery
nda
lead optimization
drug development
lead compound
marketing of drug
spectrophotometer
absorbance
beer's law
lambert's law
colorimetry
spectroscopy
transmittance
potassium channel openers
anti-angina
See more